Anemia from Hepatitis C Drugs May Be Genetically Determined
New find may offer protection against hepatitis C treatment-related anemia
Scientists have discovered two functional variants in the inosine triphosphatase (ITPA) gene that protect patients with hepatitis C virus (HCV) against anemia brought on by antiviral treatment.
The ability to identify those patients protected against treatment-induced anemia will ensure completion of antiviral therapy and successful elimination of the virus.
Continue reading this entire article: